Publications by authors named "Michael W Draper"

Claim this Profile
S
Selective estrogen receptor modulators: an update on recent clinical findings.
Wendy Shelly, Michael W Draper, Venkatesh Krishnan, Mayme Wong, Robert B Jaffe

Obstet Gynecol Surv· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raloxifene: a selective estrogen-receptor modulator for postmenopausal osteoporosis - a clinical update on efficacy and safety.
Chad L Deal, Michael W Draper

Womens Health (Lond)· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women.
Michael W Draper, Leo Plouffe

Obstet Gynecol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation.
Andrew G Geiser, Conrad W Hummel, Michael W Draper, Judith W Henck, Ilene R Cohen

Endocrinology· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
Brigitte Uebelhart, François Herrmann, Imre Pavo, Michael W Draper, René Rizzoli

J Bone Miner Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
Ian R Reid, Richard Eastell, Ignac Fogelman, Jonathon D Adachi, Amy Rosen, Michael W Draper

Arch Intern Med· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of selective estrogen receptor modulators (SERMs) in postmenopausal health.
Michael W Draper

Ann N Y Acad Sci· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
Elaine E Jolly, Nina H Bjarnason, Patrick Neven, Leo Plouffe, C Conrad Johnston, Michael W Draper

Menopause· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinical evidence for the unique nature of individual selective estrogen receptor modulators.
Michael W Draper, William W Chin

Clin Obstet Gynecol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis